Neuroactive probiotics

BioEssays

Volumn 33, Issue 8, 2011, Pages 562-

  Reid, Gregor ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; BACTERIAL STRAIN; BIFIDOBACTERIUM; DEPRESSION; DRUG EFFECT; ENTERITIS; HUMAN; IMMUNOMODULATION; LACTOBACILLUS ACIDOPHILUS; MENTAL HEALTH; NONHUMAN; NOTE; PAIN;

BACTERIA; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL TRACT; HUMANS; PROBIOTICS;

EID: 79960451790     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100074     Document Type: Note

References (4)

1. Bienenstock J, Collins S. 2010. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms. Clin Exp Immunol 160: 85-91.
2. Lyte M. 2011. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. BioEssays 33: 574-81.
3. Steidler L, Neirynck S, Huyghebaert N, Snoeck V, et al. 2003. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21: 785-9.
4. Rousseaux C, Thuru X, Gelot A, Barnich N, et al. 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13: 35-7.